Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

December 1, 2019

Study Completion Date

December 30, 2019

Conditions
Laparoscopic Colon ResectionPerioperative Analgesia
Interventions
DRUG

IV Saline bolus and infusion

Intravenous bolus of normal saline at induction 3 day postoperative infusion of normal saline administered by ambit pump

DRUG

IP Saline bolus and infusion

Intraperitoneal bolus of normal saline down first port site. 3 day post operative intraperitoneal infusion of normal saline via an intraperitoneal line inserted by the surgeon. Infusion will be administered by ambit pump.

DRUG

IV lignocaine bolus and infusion

Intravenous lignocaine bolus at induction. 3 day postoperative IV infusion of lignocaine administered by ambit pump

DRUG

IP Lignocaine bolus and infusion

Intraperitoneal bolus of lignocaine down first port site. 3 day post operative intraperitoneal infusion of lignocaine via an intraperitoneal line inserted by the surgeon. Infusion will be administered by ambit pump.

Trial Locations (1)

Unknown

Manukau Surgical Centre, Middlemore Hospital, Auckland

All Listed Sponsors
lead

University of Auckland, New Zealand

OTHER

NCT03105193 - Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections | Biotech Hunter | Biotech Hunter